Visura Technologies, a privately owned medical device company in Minneapolis, has unveiled a new initiative to advance transesophageal echocardiography (TEE) imaging with the TEECAD mini.

Following their 2023 milestone of introducing the first digital camera for real-time visualization with adult TEE probes, Visura is now developing a smaller camera system for probes designed for adult patients with unique anatomical needs not addressed by standard TEE probe sizes.

At the American Society of Echocardiography (ASE) 2024, Visura will be at booth 740 to gather feedback from key opinion leaders on the mini-TEE probes.

These insights will help drive the TEECAD mini program forward. Clinicians will also have the chance to experience the TEECAD System at the TEECAD Innovation Station, which demonstrates the benefits of real-time visualization.

The TEECAD mini program is a part of several recent achievements for Visura. The company has expanded its clinical and commercialization teams and has increased evaluations and engagement at major medical centers by 85% over the last quarter. Visura's customers include some of the nation's largest and most prestigious hospital systems.

“The introduction of TEECAD was a major advancement in TEE procedures. Now, with the industry moving towards smaller probes, there is a greater need for a camera that allows real-time visualization during probe placement.”

“We are seeing significant momentum at Visura,” said Christine Horton, president and CEO of Visura Technologies. “As we expand in key commercial areas and innovate to meet market demands, the smaller TEECAD is set to become a vital part of our patent-protected product portfolio.

Team looks forward to engaging with cardiologists at ASE to gain insights and explore new opportunities for providing real-time visualization in TEE procedures.”

Clinical data supports the effectiveness of TEECAD. At last year’s ASE meeting, Dr. Sunil Mankad, Director of Transesophageal Echocardiography at Mayo Clinic, presented data showing TEECAD’s safety and effectiveness in imaging the esophagus and surrounding structures.

The technology shortened the time needed for accurate probe placement, increased first-pass intubation success, and resulted in no adverse events. TEECAD also has the potential to reduce TEE costs by minimizing the need for additional staff during intubations, making it a promising new tool for cardiology TEE procedures.






Source: medicalalley.org

Report Abuse